Neither compound is FDA-approved for human use
CJC1295/Ipamorelin, Epitalon, B P C 157, Thymosin Alpha-1, Thymosin Beta-4 CJC1295/Ipamorelin, PT141, Epitalon CJC/Ipamorelin, MOTS-c, AOD9604 Thymosin Alpha-1, B P C 157, GHK-cu CJC/Ipamorelin, MOTS-c, B P C 157 Our therapeutic peptide protocols are developed and based on a deep understanding of human physiology and 20+ years of clinical experience in performance medicine Were experts in synergistic peptide stacks, both from research and having worked with thousands of patients
doi.org/10.1046/j.1524-475X.1994.20406.x Regulatory Status FDA, WADA anti-doping, and compounding status provided for research context
There is a lack of long-term effects data, including concerns about abnormal cell growth and the need for ongoing evaluation and monitoring
At a 1 mg/ml concentration (5 ml total liquid), a 5 mg vial holds about 50 units of dose volume per ml